Nectar Lifescience Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹0.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 100.00 per cent from ₹0.71 crore. This corresponds to a year-on-year *(YoY) decline of 100.00 per cent.
Operating Profit
Operating Profit stands at ₹-55.28 crore, reflecting a quarter-on-quarter *(QoQ) increase of 68.55 per cent from ₹-175.76 crore. This corresponds to a year-on-year *(YoY) decline of 1,38,100.00 per cent.
PBDT
PBDT stands at ₹3.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 101.88 per cent from ₹-175.74 crore. This corresponds to a year-on-year *(YoY) decline of 58.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 101.85 per cent from ₹-175.85 crore. This corresponds to a year-on-year *(YoY) decline of 59.17 per cent.
Net Profit
Net Profit stands at ₹14.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 108.11 per cent from ₹-176.01 crore. This represents a 82.02 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Nectar Lifescience Ltd Earnings
- YOY
- QOQ
Nectar Lifescience Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Nectar Lifescience Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Nectar Lifescience Ltd Financial Reports
Nectar Lifescience Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Nectar Lifesci. | -2.24% | -4.46% | 20.43% | -15.67% | -18.86% | -46.75% |
| Gennex Lab. | 0.48% | -0.48% | 29.34% | -14.45% | -36.64% | -21.04% |
| Aarey Drugs | -1.97% | 4.23% | 57.89% | 30.31% | -1.03% | 60.59% |
| Syschem (India) | -1.61% | -2.08% | 18.11% | 11.90% | -7.02% | 27.50% |
| BDH Industries | -1.02% | -0.50% | 4.50% | -1.41% | -12.03% | 37.92% |
| Oxygenta Pharma | 7.04% | 2.47% | 23.49% | -2.37% | -7.63% | -36.76% |
| Sanjiv.Parant. | -0.30% | -3.04% | 19.86% | -8.74% | -16.38% | -29.73% |
Company Info
Company Information
Chairman & Managing Director : Sanjiv Goyal
Independent Non Exe. Director : Rupinder Tewari
Independent Non Exe. Director : Kuldip Kumar Bhasin
Independent Non Exe. Director : Indu Pal Kaur
Executive Director : Surulichamy Senthilkumar
Company Sec. & Compli. Officer : Sanjaymohan Singh Rawat
WTD & Director (Finance) : Sushil Kapoor